Skip to main content

Pathology Grand Rounds - Updates from the 2020 WHO 5th Edition Classification of Female Genital Tumors

July 30, 2021 - 12:00pm to 1:00pm
Lori Renee Scanga, MD, PhD, The University of North Carolina at Chapel Hill

At the conclusion of this activity, learners should be able to:

* Understand ICD-O coding (International Classification of Diseases for Oncology)

* Know the recommended terminology for ovarian serous borderline tumors with micropapillary/cribriform pattern feedback

* Know the new molecular classification of endometrioid endometrial carcinoma

* Know the new classification of lower female genital tract (cervix, vagina, and vulva) precursor lesions, squamous cell carcinomas, and adenocarcinomas by HPV etiology (HPV-Associated and HPV-Independent)

* Know about newly described mutations and their associations in gynecologic cancer: SWI/SNF complex mutations including various SMARC deficient tumors, high grade endometrial stromal sarcoma with BCOR genetic abnormalities , NTRK-rearranged spindle cell neoplasm, TFE3 translocation associated PEComa, and Fumarate hydratase-deficient leiomyoma associated with Hereditary leiomyomatosis and Renal cell carcinoma (HLRCC syndrome)